News on Dufour %26 Company from BioPortfolio.com http://www.BioPortfolio.com Consolidated Dufour %26 Company news from BioPortfolio.com Wed, 10 Feb 2010 15:19:10 GMT en Hybrigenics receives positive answers from EMEAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021351&HITNO=0&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dufour%20%26%20Company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021351&THISHREF=http://c.moreover.com/click/here.pl%3fz2527198370%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021351&HITNO=0&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dufour%20%26%20Company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021351&THISHREF=http://c.moreover.com/click/here.pl%3fz2527198370%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: EMEA Gives Official Scientific Advice On Clinical Phase IIb Efficacy Study Of Inecalcitol In Hormone-refractorhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011513&HITNO=1&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dufour%20%26%20Company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011513&THISHREF=http://c.moreover.com/click/here.pl%3fz2522980796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011513&HITNO=1&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dufour%20%26%20Company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011513&THISHREF=http://c.moreover.com/click/here.pl%3fz2522980796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: AACC Expands Global Patient Education Networkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993918&HITNO=2&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dufour%20%26%20Company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993918&THISHREF=http://c.moreover.com/click/here.pl%3fz2514809739%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993918&HITNO=2&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dufour%20%26%20Company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993918&THISHREF=http://c.moreover.com/click/here.pl%3fz2514809739%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comClincial Laboratory News: Hybrigenics receives authorization to dose prostate cancer patients twice daily with oral inecalcitolhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3873291&HITNO=3&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dufour%20%26%20Company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3873291&THISHREF=http://c.moreover.com/click/here.pl%3fz2449946849%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3873291&HITNO=3&MSIZE=4&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dufour%20%26%20Company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3873291&THISHREF=http://c.moreover.com/click/here.pl%3fz2449946849%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: